. "1.3 hours"@en . . . . . "Enteric bacteria and other eubacteria"@en . . . "Single 5000 mg/kg oral doses of cefprozil caused no mortality or signs of toxicity in adult, weaning or neonatal rats, or adult mice. A single oral dose of 3000 mg/kg caused diarrhea and loss of appetite in cynomolgus monkeys, but no mortality."@en . . . "Take without regard to meals."@en . . . . " "@en . . "92665-29-7"@en . . . . . "Cefprozil is a cephalosporin antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections."@en . . . . . . "Cefprozilum"@en . . "Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor."@en . . "36%"@en . . . . . . . . "Cefprozil"@en . . . . "Cefprozil"@en . . . . . . "* 0.23 L/kg"@en . . . . . "Cefzil"@en . . . . "Cefprozil anhydrous"@en . . . . . . . . . . "* 3 mL/min/kg [fasting subjects]"@en . . . . . . . . . . . . . . " "@en . . . "Oral bioavailability is approximately 95%."@en . . . . . . "approved"@en . . . . . . . . . . "For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph"@en . . . . "Julia Greil, Johannes Ludescher, Siegfried Wolf, \"Intermediates in cefprozil production.\" U.S. Patent US07355041, issued April 08, 2008."@en . "Cefprozilo"@en . . .